Without a nasal vaccine, the U.S. edge in fighting Covid is on the line
politico.com
economics
2022-10-15 11:00:00

'Countries where transmission is reduced are going to be healthier, are going to have stronger economies. And the U.S. needs to catch up,' said Marty Moore, the founder and chief scientific officer of Meissa Vaccines, a small biotech company that's trying to develop a nasal vaccine in the U.S.

Stopping transmission

Many scientists believe the nose could hold the secret to stopping coronavirus transmission, but there's no consensus yet on whether nasal vaccines could be more effective than injectable ones, as evidence from clinical trials is necessary to prove it.
